BB-031
- Generic Name
- BB-031
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 156
- Registration Number
- NCT06226805
- Locations
- 🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇨🇦University of Alberta Hospital, Edmonton, Alberta, Canada
Study of DTRI-031 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy VolunteersPharmacokineticsPharmacodynamics
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-08-13
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Basking Biosciences, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT05005520
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath